Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer

Rayzel Fernandes, Theresa E. Hickey, Wayne Tilley, Luke Selth

Research output: Contribution to journalReview articlepeer-review

22 Citations (Scopus)


The androgen receptor (AR) is a ligand-activated transcription factor that drives prostate cancer. Since therapies that target the AR are the mainstay treatment for men with metastatic disease, it is essential to understand the molecular mechanisms underlying oncogenic AR signaling in the prostate. miRNAs are small, non-coding regulators of gene expression that play a key role in prostate cancer and are increasingly recognized as targets or modulators of the AR signaling axis. In this review, we examine the regulation of AR signaling by miRNAs and vice versa and discuss how this interplay influences prostate cancer growth, metastasis and resistance to therapy. Finally, we explore the potential clinical applications of miRNAs implicated in the regulation of AR signaling in this prevalent hormone-driven disease.
Original languageEnglish
Pages (from-to)R237–R257
Number of pages21
JournalEndocrine-Related Cancer
Issue number5
Publication statusPublished - 1 May 2019
Externally publishedYes


  • microRNA
  • androgen receptor
  • prostate cancer
  • biomarkers
  • therapy


Dive into the research topics of 'Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer'. Together they form a unique fingerprint.

Cite this